ClinicalTrials.gg
Drug

Mirikizumab clinical trials

Also written LY3074828 and Omvoh.

studies test it
44
open now
11
in phase 3
13
first study started
2013

How each study uses mirikizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the mirikizumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Oct 2023 · OMVOH · BLA 761279 (FDA, Drugs@FDA)
European Union
26 May 2023 · Omvoh · EMEA/H/C/005122 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Mirikizumab
27
Mirikizumab - SC
4
Mirikizumab IV
3
Mirikizumab SC
3
Mirikizumab - IV
3

Brand

Omvoh
3

Development codes

LY3074828
34

Studies by the year they started

44 studies that test it; most in 2018 (10)

Studies that test mirikizumab, by start year
YearStudies
20131
20152
20162
20173
201810
20192
20204
20213
20222
20232
20243
20253
20267

By phase

A phase 1/2 study counts in both.

Phase 1
17
Phase 2
4
Phase 3
13
Phase 4
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 36 · Other 8

Eli Lilly and Company (35) · University Hospital Schleswig-Holstein (2) · University of North Carolina, Chapel Hill (1) · Showa Inan General Hospital (1) · Specialty Networks Research. (1) · Icahn School of Medicine at Mount Sinai (1) · Rubix LS (1) · Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (1)

Often tested with

Tested in the same studies.

LY900021 (2) · Vedolizumab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test mirikizumab.

Studies

Open first, then newest update. How each study uses mirikizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 44

See all 44 studies that test mirikizumab →

Given beside what is tested · 7 — mirikizumab is usual care or a partner of the new treatment

Codes

What other systems call mirikizumab · ClinicalTrials.gg INT001359

  • MeSH (NLM) C000708407mirikizumabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) Z7HVY03PHPMIRIKIZUMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q55641096mirikizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C170182MirikizumabOne source FDA
  • DrugBank DB14910One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.